Biofrontera (BFRI) Depreciation & Amortization (CF) (2020 - 2025)

Biofrontera's Depreciation & Amortization (CF) history runs 6 years deep, the most recent figure standing at $36000.0 for Q4 2025.

• On a quarterly basis, Depreciation & Amortization (CF) fell 5.26% year-over-year to $36000.0 in Q4 2025; TTM through Dec 2025 was $100000.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $138000.0, down 67.22% from the prior year.
• Depreciation & Amortization (CF) rose to $36000.0 in Q4 2025 per BFRI's latest filing, from $17000.0 in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $38000.0 in Q4 2024 and bottomed at $17000.0 in Q3 2025.
• The 5-year median for Depreciation & Amortization (CF) is $23500.0 (2023), against an average of $25350.0.
• Across the five-year window, Depreciation & Amortization (CF) decreased 22.86% in 2021 and soared 80.95% in 2024, its largest moves.
• Year by year, Depreciation & Amortization (CF) stood at $27000.0 in 2021, then slipped by 22.22% to $21000.0 in 2022, then changed by 0.0% to $21000.0 in 2023, then surged by 80.95% to $38000.0 in 2024, then slipped by 5.26% to $36000.0 in 2025.
• Per Business Quant, the three latest BFRI Depreciation & Amortization (CF) figures stand at $36000.0 (Q4 2025), $17000.0 (Q3 2025), and $22000.0 (Q2 2025).